Anticipating Resistance in HABP/VABP: Strategies to Improve Empiric Regimens in the ICU

Learn approaches to identify patients with HABP/VABP at risk for extensively drug–resistant organisms based on local resistance patterns and patient-specific factors, along with strategies, such as rapid diagnostic testing, advanced antibiograms, and clinical prediction scores, to help reduce time to effective therapy.

Marion Elligsen, BScPhm, MSc, RPh, ACPR Keith S. Kaye, MD, MPH Andrew Shorr, MD, MPH, MBA Released: October 21, 2022

Learn the answers to commonly asked questions about empiric antibiotic selection for HABP/VABP in the ICU.

Marion Elligsen, BScPhm, MSc, RPh, ACPR Keith S. Kaye, MD, MPH Andrew Shorr, MD, MPH, MBA Released: November 18, 2022

In this on-demand webcast from a live symposium at IDWeek 2022, expert faculty discuss strategies to anticipate resistance and improve timely and effective empiric HABP/VABP regimens in the ICU including use of rapid diagnostic testing, advanced antibiograms (eg, weight-incidence syndromic combination antibiograms, escalation antibiograms) and clinical prediction scores.

Marion Elligsen, BScPhm, MSc, RPh, ACPR Keith S. Kaye, MD, MPH Andrew Shorr, MD, MPH, MBA Released: November 16, 2022

Introduction

Strategies for Empiric Therapy in HABP/VABP

Key Aspects of Antimicrobial Resistance in HABP/VABP

Strategies for Effective Antimicrobial Resistance Risk Stratification

Question and Answer Session

Hear from expert faculty as they answer questions and discuss key considerations when selecting empiric antibiotic therapy in patients with HABP/VABP in the ICU.

Marion Elligsen, BScPhm, MSc, RPh, ACPR Keith S. Kaye, MD, MPH Andrew Shorr, MD, MPH, MBA Released: December 6, 2022